Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer

Authors
Crino, L Calandri, C Maestri, A Marrocolo, F
Citation
L. Crino et al., Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer, ONCOLOGY-NY, 15(3), 2001, pp. 40-42
Citations number
21
Categorie Soggetti
Oncology
Journal title
ONCOLOGY-NEW YORK
ISSN journal
08909091 → ACNP
Volume
15
Issue
3
Year of publication
2001
Supplement
6
Pages
40 - 42
Database
ISI
SICI code
0890-9091(200103)15:3<40:GACCIE>2.0.ZU;2-S
Abstract
A number of randomized clinical trials now support the conclusion that the combined-modality regimen that includes gemcitabine (Gemzar) and cisplatin (Platinol) may improve survival in disseminated non-small-cell lung cancer. Cisplatin is considered to be the "backbone" of this combination chemother apy due to its proven activity. The regimen of gemcitabine and cisplatin ha s been tested and is now considered among the most active combinations in t he treatment of disseminated non-small-cell lung cancer.